Journal article

The roles of purinergic signaling during gastrointestinal inflammation

JA Roberts, MK Lukewich, KA Sharkey, JB Furness, GM Mawe, AE Lomax

Current Opinion in Pharmacology | Published : 2012

Abstract

Extracellular purines play important roles as neurotransmitters and paracrine mediators in the gastrointestinal (GI) tract. Inflammation of the GI tract causes marked changes in the release and extracellular catabolism of purines, and can modulate purinoceptor expression and/or signaling. The functional consequences of this include suppression of the purinergic component of inhibitory neuromuscular and neurovascular transmission, increased release of purines from immune and epithelial cells, loss of enteric neurons to damage through P2X7 purinoceptors, and enhanced activation of pain fibres. The purinergic system represents an important target for drug therapies that may improve GI inflammat..

View full abstract

University of Melbourne Researchers

Grants

Awarded by National Institutes of Health


Funding Acknowledgements

Work in the authors' laboratories is supported by Canadian Institutes of Health Research (MKL, KAS, AEL), National Institutes of Health (NIH grant DK62267; GMM), the National Health and Medical Council of Australia (grant 1006035; JBF), and the Crohn's and colitis foundation of Canada (AEL). KAS is an Alberta Innovates-Health Solutions Medical Scientist and holds the Crohn's and Colitis Foundation of Canada Chair in IBD Research at the University of Calgary.